Literature DB >> 29491056

Glucans and Cancer: Comparison of Commercially Available β-glucans - Part IV.

Vaclav Vetvicka1, Jana Vetvickova2.   

Abstract

BACKGROUND/AIM: β-Glucans are well-established immunomodulators with strong effects across all immune reactions. Due to the extensive amount of studies, glucans are steadily progressing from a non-specific immunomodulator to a licensed drug. However, direct comparisons of higher numbers of different glucans are rare.
MATERIALS AND METHODS: In this study, we used 16 different glucans isolated from yeasts, mushroom, algae, and oat and compared their effects on phagocytosis, IL-2 production, antibody secretion, and inhibition of three experimental cancer models.
RESULTS: Our results showed significant differences among tested glucans, showing that despite the fact that glucans in general have strong stimulating effects on most aspects of the immune system, it is necessary to choose the right glucan.
CONCLUSION: Based on our studies, we can conclude that highly purified and active glucans have significant pleiotropic effects. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Glucan; IL-2; cancer; mushroom; phagocytosis; yeasts

Mesh:

Substances:

Year:  2018        PMID: 29491056     DOI: 10.21873/anticanres.12355

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Synthesis and Evaluation of Oligomeric Thioether-Linked Carbacyclic β-(1→3)-Glucan Mimetics.

Authors:  Peng Wen; Václav Větvička; David Crich
Journal:  J Org Chem       Date:  2019-04-15       Impact factor: 4.354

Review 2.  Cell wall polysaccharides: before and after autolysis of brewer's yeast.

Authors:  Jinjing Wang; Mengqi Li; Feiyun Zheng; Chengtuo Niu; Chunfeng Liu; Qi Li; Jinyuan Sun
Journal:  World J Microbiol Biotechnol       Date:  2018-08-20       Impact factor: 3.312

3.  Anti-Cancerous Potential of Polysaccharides Derived from Wheat Cell Culture.

Authors:  Alima Murtazina; Gloria Ruiz Alcala; Yaiza Jimenez-Martinez; Juan Antonio Marchal; Anel Tarabayeva; Elmira Bitanova; Gordon McDougall; Nazira Bishimbayeva; Houria Boulaiz
Journal:  Pharmaceutics       Date:  2022-05-20       Impact factor: 6.525

4.  Synthesis and Evaluation of 1,5-Dithia-d-laminaribiose, Triose, and Tetraose as Truncated β-(1→3)-Glucan Mimetics.

Authors:  Xiaoxiao Liao; Václav Větvička; David Crich
Journal:  J Org Chem       Date:  2018-12-04       Impact factor: 4.354

Review 5.  Trained innate immunity.

Authors:  Borros Arneth
Journal:  Immunol Res       Date:  2021-01-16       Impact factor: 2.829

Review 6.  Trained Innate Immunity of Fish Is a Viable Approach in Larval Aquaculture.

Authors:  Zuobing Zhang; Heng Chi; Roy A Dalmo
Journal:  Front Immunol       Date:  2019-01-25       Impact factor: 7.561

Review 7.  Beta Glucan: Supplement or Drug? From Laboratory to Clinical Trials.

Authors:  Vaclav Vetvicka; Luca Vannucci; Petr Sima; Josef Richter
Journal:  Molecules       Date:  2019-03-30       Impact factor: 4.411

Review 8.  Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements.

Authors:  Kosagi-Sharaf Rao; Vaddi Suryaprakash; Rajappa Senthilkumar; Senthilkumar Preethy; Shojiro Katoh; Nobunao Ikewaki; Samuel J K Abraham
Journal:  Front Immunol       Date:  2020-07-09       Impact factor: 7.561

9.  Spatial Distribution of Glucan Type and Content between Caps and Stalks in Pleurotus eryngii: Impact on the Anti-inflammatory Functionality.

Authors:  Vaclav Vetvicka; Ofer Gover; Hilla Hayby; Ofer Danay; Nirit Ezov; Yitzhak Hadar; Betty Schwartz
Journal:  Int J Mol Sci       Date:  2018-10-28       Impact factor: 5.923

Review 10.  Effects of Medicinal Fungi-Derived β-Glucan on Tumor Progression.

Authors:  Vaclav Vetvicka; Tamara V Teplyakova; Alexandra B Shintyapina; Tatiana A Korolenko
Journal:  J Fungi (Basel)       Date:  2021-03-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.